(Mol Vis[TA])
3,942 results
  • Assessing mitochondrial phenotypes in a cybrid model of dry age-related macular degeneration. [Journal Article]
    Mol Vis. 2026; 32:196-208.Dohl J, Zaw NL, … Kenney MCMV
  • CONCLUSIONS: Taken together, this study suggests that these DAMD cybrids do not fully recapitulate DAMD mitochondrial pathology, though this is limited to the study population of males with the H mtDNA haplogroup. However, there may be a niche for cybrid cell lines in investigating mitochondrial DNA phenotypes in patients with DAMD. This is likely because DAMD is a multifactorial disease, dependent upon an individual's genetics and the retinal microenvironment.
  • RNA interference to reduce Egr1 expression in rods delays retinal degeneration in a model of retinitis pigmentosa. [Journal Article]
    Mol Vis. 2026; 32:102-118.Merolla L, Fottner A, … Grimm CMV
  • CONCLUSIONS: Egr1 upregulation is a consistent early marker of photoreceptor stress, independent of the nature of the underlying stimulus. Since moderate support for cell survival and preservation of retinal morphology was achieved through the downregulation of Egr1 expression in rods, but not in cones of the Rho[P23H/+] mouse, the function of EGR1 in degenerative processes may be cell type specific. Although Egr1 may contribute to disease progression, it is unlikely to be a causative factor for degeneration. Our findings underscore the complexity of the transcriptional response in retinal degeneration and suggest that Egr1 is a secondary effector of degenerative processes in rods.
  • Review: The role of microglia in diabetic retinopathy and its potential as a therapeutic target. [Review]
    Mol Vis. 2026; 32:49-68.Liu W, Jiang J, … Chen XMV
  • Diabetic retinopathy (DR) is a common and severe complication of diabetes, which poses a serious threat to vision, and its pathogenesis is complex. Inflammatory response plays a crucial role in the progression of DR, but currently, anti-vascular endothelial growth factor therapy, the preferred treatment for DR, only targets the vascular part. Therefore, determining a treatment method targeting th…